153 related articles for article (PubMed ID: 37904652)
21. Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.
Zehnder P; Studer UE; Daneshmand S; Birkhäuser FD; Skinner EC; Roth B; Miranda G; Burkhard FC; Cai J; Skinner DG; Thalmann GN; Gill IS
BJU Int; 2014 Apr; 113(4):554-60. PubMed ID: 24131453
[TBL] [Abstract][Full Text] [Related]
22. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes.
Bochner BH; Dalbagni G; Marzouk KH; Sjoberg DD; Lee J; Donat SM; Coleman JA; Vickers A; Herr HW; Laudone VP
Eur Urol; 2018 Oct; 74(4):465-471. PubMed ID: 29784190
[TBL] [Abstract][Full Text] [Related]
23. Pelvic lymph node dissection in prostate cancer.
Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
[TBL] [Abstract][Full Text] [Related]
24. Impact of surgical margin and extent of lymphadenectomy on oncologic outcomes in plasmacytoid urothelial carcinoma.
Davaro F; Davaro E; Rose K; Murthy P; Huelster H; Naidu S; Camperlengo L; Grass GD; Vosoughi A; Chumbalkar V; Jain RK; Zemp L; Yu A; Poch MA; Spiess PE; Gilbert SM; Sexton WJ; Li R
Urol Oncol; 2023 Sep; 41(9):389.e7-389.e13. PubMed ID: 36959058
[TBL] [Abstract][Full Text] [Related]
25. Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder.
Kosiba M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Mansour M; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
Clin Genitourin Cancer; 2022 Apr; 20(2):195.e1-195.e8. PubMed ID: 34906434
[TBL] [Abstract][Full Text] [Related]
26. A systematic review and meta-analysis of comparative studies on the efficacy of extended pelvic lymph node dissection in patients with clinically localized prostatic carcinoma.
Gao L; Yang L; Lv X; Bu S; Wan F; Qian S; Wei Q; Han P; Fan T
J Cancer Res Clin Oncol; 2014 Feb; 140(2):243-56. PubMed ID: 24369378
[TBL] [Abstract][Full Text] [Related]
27. Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy?
Park J; Kim S; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
World J Urol; 2011 Aug; 29(4):443-9. PubMed ID: 21240505
[TBL] [Abstract][Full Text] [Related]
28. Trends of Lymph Node Outcomes in Partial Cystectomy for Muscle-Invasive Urothelial Carcinoma of the Bladder.
Klose C; Gordon O; Sparks A; Whalen M
Clin Genitourin Cancer; 2023 Dec; 21(6):703-709. PubMed ID: 37336704
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classification.
Sakura Y; Yamashita R; Notsu A; Usui K; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M
Int J Urol; 2024 Jul; 31(7):785-792. PubMed ID: 38606834
[TBL] [Abstract][Full Text] [Related]
30. Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template.
Fransen van de Putte EE; Hermans TJ; Werkhoven Ev; Mertens LS; Meijer RP; Bex A; Wassenaar AE; van der Poel HG; van Rhijn BW; Horenblas S
Urol Oncol; 2015 Dec; 33(12):504.e19-24. PubMed ID: 26329817
[TBL] [Abstract][Full Text] [Related]
31. Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification model.
Al-Alao O; Mueller-Leonhard C; Kim SP; Amin A; Tucci C; Kott O; Mega A; Golijanin D; Gershman B
Urol Oncol; 2020 Mar; 38(3):76.e19-76.e28. PubMed ID: 31590968
[TBL] [Abstract][Full Text] [Related]
32. Significance of perivesical lymph nodes in radical cystectomy for bladder cancer.
Hu B; Satkunasivam R; Schuckman A; Sherrod A; Cai J; Miranda G; Daneshmand S
Urol Oncol; 2014 Nov; 32(8):1158-65. PubMed ID: 25238701
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
[TBL] [Abstract][Full Text] [Related]
34. Extended pelvic lymph node dissection in muscle invasive bladder cancer.
Katims AB; Bochner BH
Curr Opin Urol; 2023 Jul; 33(4):252-257. PubMed ID: 37021936
[TBL] [Abstract][Full Text] [Related]
35. Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection.
Heck MM; Koll FJ; Retz M; Autenrieth M; Magg K; Lunger L; Gschwend JE; Nawroth R
Urol Oncol; 2020 Jul; 38(7):639.e11-639.e19. PubMed ID: 32146127
[TBL] [Abstract][Full Text] [Related]
36. Extended Pelvic Lymph Node Dissection in Bladder Cancer.
Li R; Petros FG; Davis JW
J Endourol; 2018 May; 32(S1):S49-S54. PubMed ID: 29774757
[TBL] [Abstract][Full Text] [Related]
37. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience.
Iyer G; Tully CM; Zabor EC; Bochner BH; Dalbagni G; Herr HW; Donat SM; Russo P; Ostrovnaya I; Regazzi AM; Milowsky MI; Rosenberg JE; Bajorin DF
Clin Genitourin Cancer; 2020 Oct; 18(5):387-394. PubMed ID: 32273235
[TBL] [Abstract][Full Text] [Related]
39. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
Moschini M; Morlacco A; Briganti A; Hu B; Colombo R; Montorsi F; Frank I; Daneshmand S; Karnes RJ
Eur Urol Focus; 2018 Mar; 4(2):245-251. PubMed ID: 28753820
[TBL] [Abstract][Full Text] [Related]
40. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping.
Bochner BH; Cho D; Herr HW; Donat M; Kattan MW; Dalbagni G
J Urol; 2004 Oct; 172(4 Pt 1):1286-90. PubMed ID: 15371825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
